Upregulation of A2A adenosine receptor expression by TNF-α in PBMC of patients with CHF: a regulatory mechanism of inflammation
详细信息    查看全文
文摘
Tumor necrosis factor (TNF)-α plays a role in congestive heart failure (CHF). A2A adenosine receptor (A2AR) activation on immune cells putatively reduces the release of cytokines contributing to CHF progression. The study is aimed at determining the role of the A2AR in the modulation of TNF-α production, and the ex vivo effect of TNF-α on A2AR in peripheral blood mononuclear cells (PBMC) from CHF patients.

Methods and results

Plasma levels of TNF-α and TNF-α production from lipopolysaccharide (LPS)-stimulated PBMC were evaluated in 26 CHF patients in comparison to controls. The effects of the A2AR agonist CGS-21680 and antagonist ZM-241385 on TNF-α production from PBMC were also evaluated. Finally, reverse transcriptase-polymerase chain reaction and Western blot analyses of A2AR in PBMC were performed in TNF-α–treated and untreated cells. TNF-α production from LPS-stimulated PBMC was enhanced in CHF patients with respect to controls. CGS-21680 blunted TNF-α production in both groups; ZM-241385 reverted this effect. A2AR expression in PBMC was higher in CHF patients than in controls. TNF-α addition produced an increase in A2AR in PBMC from controls but not in PBMC from CHF patients.

Conclusions

PBMC from CHF patients show an upregulation of A2AR-mediated inhibition of TNF-α, which may represents a mechanism of protection against inappropriate cytokine production.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700